Skip to content
Clinical trials are an essential part of the development and approval of new medical treatments. A growing issue within the clinical research community is […]
New strategies for increasing diversity in clinical trials Read More »
Massachusetts Governor Maura Healey’s administration is working with the legislature and a coalition of industry leaders to plan the next reauthorization of the Massachusetts
Gov. Healey plans to reauthorize Massachusetts Life Sciences Initiative Read More »
“The policy environment is something that a lot of people seem to think is this separate, strange thing that has very little to do
Enhancing public health preparedness through policy and partnership Read More »
A proposal to provide the first overhaul of European Union pharma regulation in 20 years takes some positive steps but would still leave a
Asian-Pacific countries and the United States are promoting biotech development through special programs to encourage their domestic industry combined with concerted efforts to attract
How the U.S. and Asia Pacific are collaborating to grow biotech innovation Read More »
It’s official: The 2023 BIO International Convention is open! The four-day event includes 150 sessions featuring 800 speakers. An incredible lineup of experts will
Lift off for BIO International Convention 2023 Read More »
A new class of Alzheimer’s drugs will be available to patients on Medicare – but only if the medicine has received “traditional approval” and
Medicare confirms registry requirement for new class of Alzheimer’s drugs Read More »
Up-close-and-personal stories of patients with a range of disorders will be broadcast throughout this week at the Biotechnology Innovation Organization (BIO) International Convention in
Film festival kicks off BIO International Convention Read More »
On May 25, 2023, the Biotechnology Innovation Organization (BIO) and dozens of other biotechnology organizations sent a letter to congressional leaders calling for more
The U.S. Codex Office needs more funding – here’s why Read More »
The drug price controls in the Inflation Reduction Act (IRA) will have a far more serious impact on new drug development than previously expected,
IRA means 40% reduction in new drugs over 10 years, report finds Read More »
